Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
卡培他滨和拉帕替尼联合或不联合IMC-A12(西妥昔单抗)治疗既往接受过曲妥珠单抗和化疗的HER2阳性晚期乳腺癌患者的随机II期试验:NCCTG N0733(Alliance)
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06221-8
Haddad, Tufia C; He, Jun; O'Sullivan, Ciara C; Chen, Beiyun; Northfelt, Donald; Dueck, Amylou C; Ballman, Karla V; Tenner, Kathleen S; Linden, Hannah; Sparano, Joseph A; Hopkins, Judith O; De Silva, Chamath; Perez, Edith A; Haluska, Paul; Goetz, Matthew P